Pasar al contenido principal
Veterinary Medicines

Suprelorin 9.4 mg - Implant

Authorised
  • Deslorelin acetate

Identificación del producto

Nombre del medicamento:
Suprelorin 9.4 mg - Implant
Principio activo:
Especies de destino:
  • Perros
  • Hurones
Vía de administración:
  • Vía subcutánea

Datos del producto

Principio activo y concentración:
  • Disponible únicamente en English
    11.76
    Miligramo(s)
    /
    1.00
    Implante
Forma farmacéutica:
  • Implante
Withdrawal period by route of administration:
  • Subcutaneous use
    • Perros
    • Hurones
Código Anatómico Terapéutico Químico Veterinario (ATCvet):
  • QH01CA93
Estado de la autorización:
  • Autorizado
Authorised in:
  • Alemania
  • Austria
  • Bulgaria
  • Bélgica
  • Chipre
  • Croacia
  • Dinamarca
  • Eslovaquia
  • Eslovenia
  • España
  • Estonia
  • Finlandia
  • Francia
  • Grecia
  • Hungría
  • Irlanda
  • Islandia
  • Italia
  • Letonia
  • Liechtenstein
  • Lituania
  • Luxemburgo
  • Malta
  • Noruega
  • Países Bajos
  • Polonia
  • Portugal
  • República Checa
  • Rumania; Rumanía
  • Suecia
  • United Kingdom (Northern Ireland)
Descripción del empaquetado:

Información adicional

Entitlement type:
Titular de la autorización de comercialización:
  • Virbac S.A.
Autorización de comercialización expedida:
Centros de fabricación responsables de la liberación del lote:
  • VIRBAC
País de la autorización:
No se dispone de esta información para este producto.
Autoridad responsable:
  • European Commission
Número de autorización:
No se dispone de esta información para este producto.
Fecha del cambio de estado de la autorización:

Documentos

Combined File of all Documents

Published:
Norwegian (PDF)
Download

Combined File of all Documents

Published:
Dutch (PDF)
Download

Combined File of all Documents

Published:
Portuguese (PDF)
Download

Combined File of all Documents

Published:
Swedish (PDF)
Download

Combined File of all Documents

Published:
Slovenian (PDF)
Download

Combined File of all Documents

Published:
Romanian (PDF)
Download

Combined File of all Documents

Published:
Slovak (PDF)
Download

Combined File of all Documents

Published:
Bulgarian (PDF)
Download

Combined File of all Documents

Published:
Czech (PDF)
Download

Combined File of all Documents

Published:
Danish (PDF)
Download

Combined File of all Documents

Published:
German (PDF)
Download

Combined File of all Documents

Published:
Greek (PDF)
Download

Combined File of all Documents

Published:
Finnish (PDF)
Download

Combined File of all Documents

Published:
Estonian (PDF)
Download

Combined File of all Documents

Published:
French (PDF)
Download

Combined File of all Documents

Published:
English (PDF)
Download

Combined File of all Documents

Published:
Español (PDF)
Download

Combined File of all Documents

Published:
Icelandic (PDF)
Download

Combined File of all Documents

Published:
Hungarian (PDF)
Download

Combined File of all Documents

Published:
Italian (PDF)
Download

Combined File of all Documents

Published:
Croatian (PDF)
Download

Combined File of all Documents

Published:
Lithuanian (PDF)
Download

Combined File of all Documents

Published:
Maltese (PDF)
Download

Combined File of all Documents

Published:
Latvian (PDF)
Download

Combined File of all Documents

Published:
Polish (PDF)
Download

ema-puar-suprelorin-v-109-var-ii-0007-en.pdf

Published:
English (PDF)
Download

ema-puar-suprelorin-v-109-var-ii-0032-g-en.pdf

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."